EverGlade News Archives - EverGlade Consulting

EverGlade News

EverGlade Consulting

EverGlade Funding Alert – BARDA Issues Amendment 3 to BAA for Medical Countermeasures R&D 

The Biomedical Advanced Research and Development Authority (BARDA) has recently unveiled significant updates to its Broad Agency Announcement (BAA), emphasizing a more refined and responsive approach to public health preparedness. Amendment 3, in particular, brings crucial changes to the Areas of Interest (AOIs) that are designed to align BARDA’s efforts with the evolving landscape of global health threats. 

EverGlade Funding Alert – BARDA Issues Amendment 3 to BAA for Medical Countermeasures R&D  Read More »

Covid Research

EverGlade Consulting Lands ModeX Therapeutics Up to $168 Million in BARDA Funding

EverGlade Consulting, a national consulting firm, has helped ModeX Therapeutics successfully secure up to $168 million in funding through a contract with the Biomedical Advanced Research and Development Authority (“BARDA”) to develop novel multispecific antibodies against viral infectious disease threats. How Funding Will Be Used The $168 million in BARDA funding will advance research and clinical trials for multispecific

EverGlade Consulting Lands ModeX Therapeutics Up to $168 Million in BARDA Funding Read More »

Wearable medical device

ARPA-H Solicits Proposals For REACT Program

Advanced Research Projects Agency (ARPA-H) Solicits Proposals for Resilient Extended Automatic Cell Therapies (REACT) Program The Advanced Research Projects Agency for Health (ARPA-H) is actively seeking innovative proposals through the Resilient Extended Automatic Cell Therapies (REACT) program, employing a Master Announcement Instruction (MAI) strategy for proposal submissions. This strategy enables proposers to tailor their submissions

ARPA-H Solicits Proposals For REACT Program Read More »

Female scientist in a hazmat suit researching WMD-related security challenges

DTRA BAA Weapons of Mass Destruction Amendment

DTRA BAA Outlines New Opportunity to Identify and Counter Weapons of Mass Destruction (WMD) through the Strategic Trends Research Initiative The Defense Threat Reduction Agency (DTRA) has amended its Broad Agency Announcement (BAA) to offer new funding opportunities through the Strategic Trends Research Initiative (STRI) for identifying and countering Weapons of Mass Destruction (WMD), defined

DTRA BAA Weapons of Mass Destruction Amendment Read More »

man-made fibers

ASPR-IBx RFP Update – The Need for Expanded Domestic MMF Production

The Administration for Strategic Preparedness and Response (ASPR) Program Office for Innovation and Industrial Base Expansion (IBx) is a pivotal initiative designed to strengthen and innovate the U.S. public health industrial base. Conceived in response to the challenges witnessed during the COVID-19 pandemic, IBx aims to foster collaboration across ASPR, federal entities, academia, and the

ASPR-IBx RFP Update – The Need for Expanded Domestic MMF Production Read More »

Government Contracts, OTAs, and Grants

What are OTAs, Cooperative Agreements, and Grants in Government Funding

In the intricate world of government funding, it’s easy to get lost in a maze of terminologies and contract types. For businesses, research institutions, and non-profit organizations, understanding these funding mechanisms is crucial for successful partnerships and endeavors. Among these are Other Transaction Authority (OTAs), Cooperative Agreements, and Grants. Let’s demystify them:https://youtu.be/u8pNKQmNhlw 1. Other Transaction

What are OTAs, Cooperative Agreements, and Grants in Government Funding Read More »

US Capitol Building - Guides for applying for government funding

Top 10 Guides to Apply for Government Funding

The process for obtaining government funding can vary depending on the specific program and agency. It’s crucial to thoroughly review the guidelines, eligibility criteria, and instructions provided by the funding source to increase your chances of securing funding. We’ve produced simplified guides to help you secure government funding for your project.

Top 10 Guides to Apply for Government Funding Read More »

CHIPS Act Funding Opportunities

CHIPS Act Notice of Funding Opportunity Update

The National Institute of Standards and Technology (NIST) has announced a significant funding opportunity under the CHIPS for America program. This initiative aims to stimulate long-term, economically sustainable growth in the domestic semiconductor industry, a critical sector for U.S. economic and national security. CHIPS Act Funding Opportunity Includes The funding opportunity seeks applications for projects

CHIPS Act Notice of Funding Opportunity Update Read More »

Tissue Chips

BARDA’s DRIVe Initiative: New Area of Interest Announced

The Biomedical Advanced Research and Development Authority’s (BARDA) Division of Research, Innovation, and Ventures (DRIVe) has recently announced a new area of interest (AOI) under its Broad Agency Announcement (BAA). This competitive solicitation aims to foster the development of advanced microphysiological models of human tissues, with a particular emphasis on modeling components of the immune

BARDA’s DRIVe Initiative: New Area of Interest Announced Read More »

Semiconductor

NIST’s RFI Responses Bolster the Future of Semiconductor Manufacturing in the USA

In an announcement that promises to shape the future of semiconductor manufacturing in the United States, the National Institute of Standards and Technology (NIST) has released a summary of responses to its Request for Information (RFI) concerning semiconductor-related manufacturing. In its quest to understand and respond to the challenges and opportunities in the domestic semiconductor

NIST’s RFI Responses Bolster the Future of Semiconductor Manufacturing in the USA Read More »

Digital illustration of a knee and joint representing Osteoarthritis Treatment Research

The ARPA-H NITRO Program for Osteoarthritis

EverGlade Consulting Funding Alert – Revolutionizing Osteoarthritis Treatment: The ARPA-H NITRO Program The Advanced Research Projects Agency for Health (ARPA-H) has issued a Broad Agency Announcement (BAA) for its NITRO (Novel Innovations for Tissue Regeneration in Osteoarthritis) program, which seeks proposals that will revolutionize the treatment and management of osteoarthritis (OA) by developing novel techniques

The ARPA-H NITRO Program for Osteoarthritis Read More »

Scroll to Top